You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

With passion for long-term commitment

We believe in making a difference. And our heritage proves that passion for improving patient outcome, through leading technology and integrated medtech solutions, adds value to both healthcare and investors.

The Share

  • Getinge B (STO)
  • 22 Jun 2017 18:00
  • 19.80 USD (+1.05%)

Are you looking for

Reports & presentations

Get access to the latest interim and annual reports as well as presentations or find the right one from the archive.

Share

Information about the major shareholders, share price, dividend and total return as well as sell side analysts.

Calendar

In the financial calendar you get information about upcoming events, such as coming reports.

Fact Sheet

Here you find basic information about Getinge on a one-pager, prepared for print out.

Financial data

In this section you can download annually and quarterly financial statistics.

Press releases

Get access to the latest press releases and sign up for a subscription.

IR Requests

Lars Mattsson
Head of Investor Relations
Phone: +46 10 335 0043
lars.mattsson@getinge.com

Download Annual Report

Learn more

Corporate governance

Getinge is committed to the principles of corporate governance, all in order to promote business competitiveness as well as investor confidence. 

Our Responsibility

We contribute to a sustainable future by acting socially responsible and reducing the environmental impact from our operations.

About Us

Getinge provides products and services for operating rooms, intensive-care units, hospital wards, sterilization departments and life science companies and institutions.